Capability
ArtiQ (Belgium) – AI for Lung Function Diagnostics and European Strategic Autonomy
How does ArtiQ's AI software interpret complex pulmonary function tests to detect conditions such as asthma, COPD and fibrosis?
ArtiQ: A small Belgian spin-off is quietly reshaping how doctors diagnose lung diseases. Defence-finance analysis; 35-page sourced DFM PDF report.
Full figures, sources and the complete assessment are in the report — Read the full DFM Analysis →
Part of our Research, Universities & Deep Tech and Defence & Dual-Use Companies coverage →
Original DFM publication · DFM Analysis report · 2025-08-18
A small Belgian spin-off is quietly reshaping how doctors diagnose lung diseases. ArtiQ emerged from a university lab with a clear vision: use artificial intelligence to interpret complex pulmonary function tests faster and more accurately than human experts.
In just a few years, its software has analyzed tens of thousands of lung tests at Belgian hospitals, proving that machine learning can rival top pulmonologists in detecting conditions like asthma, COPD, and fibrosis . This success has not only attracted patients and physicians – it has also drawn the attention of global industry.
This analysis answers: How does ArtiQ's AI software interpret complex pulmonary function tests to detect conditions such as asthma, COPD and fibrosis? How mature is its diagnostic AI, validated on tens of thousands of tests in Belgian hospitals, and what is its dual-use relevance? Who are its partners and customers, and what global industry interest has it attracted? What capability gaps and dependencies affect this Belgian medical-AI spin-off?
Key takeaways
- This success has not only attracted patients and physicians – it has also drawn the attention of global industry.
Continue with the full evidence
This public thread is the short analytical version. The full DFM Analysis report adds the underlying figures and data, the complete source base, and the full procurement & capital-market assessment behind this summary.
Need the full document as a standalone file? Buy the full report (PDF) — €499
Annual Professional unlocks the complete archive and DFM Intelligence (2,200+ company profiles) — See plans →
Original DFM analysis
ArtiQ (Belgium) – AI for Lung Function Diagnostics and European Strategic Autonomy
FAQ
What is ArtiQ (Belgium) – AI for Lung Function Diagnostics and European Strategic Autonomy?
ArtiQ emerged from a university lab with a clear vision: use artificial intelligence to interpret complex pulmonary function tests faster and more accurately than human experts.
Why does ArtiQ (Belgium) – AI for Lung Function Diagnostics and European Strategic Autonomy matter for European defence?
In just a few years, its software has analyzed tens of thousands of lung tests at Belgian hospitals, proving that machine learning can rival top pulmonologists in detecting conditions like asthma, COPD, and fibrosis .
Related DFM Platform threads
- Protected Satellite Communications (Operational Priorities) Capability
- Comand AI: AI-Driven Command-and-Control and Operational Planning Capability
- Kongsberg Ferrotech: Subsea Robotics for Europe’s Critical Infrastructure Security Capability
- Microamp Solutions: Enabling Secure 5G and mmWave Technologies for European Defence and Strategic Autonomy Capability
- Sensnet Analytics: European Fiber-Optic Sensing for Critical Infrastructure Security Capability
- Mynaric: Laser Communication Terminals for Secure Space Networks Capability
Explore this category Strategic Autonomy
Professional requests (internal interest signal — not a marketplace; nothing is charged or promised)
See Professional & Institutional Access — plans, group/institutional seats and contact →
Defence Finance Monitor is an analytical and informational product. It does not constitute investment advice, financial advice or a recommendation to buy or sell securities. Subscriptions run on DFM Analysis. Payments for Professional Packs are processed securely by Stripe at checkout.
Professional comments
Join the discussion on DFM Analysis.
Read & subscribe on DFM Analysis →